Stereotactic Radiosurgery and Gamma Knife
On this page
Direct answer
Gamma Knife surgery concentrates radiation from 201 cobalt-60 sources through helmet collimators of 4, 8, 14 and 18 mm onto a stereotactically defined target in a single sitting — a physically surgical act performed without an incision, distinct from fractionated radiotherapy by its precision and single-session biology. The indications are a defined list: vestibular schwannomas (marginal dose commonly 12-13 Gy preserving useful hearing in roughly half to two-thirds over the years), cerebral arteriovenous malformations under about 3 cm (obliteration in the region of 70-90 per cent over two to three years), one to four brain metastases (commonly 18-24 Gy), meningiomas of the skull base, pituitary adenomas, and trigeminal neuralgia at 75-80 Gy. The two caveats the exam exists to test: an arteriovenous malformation continues to bleed during the latency period until it obliterates, and radiosurgery does not remove anything — it induces delayed obliteration or growth arrest, so mass effect and acute compression belong to microsurgery.
What you must remember
- Hardware grammar: 201 cobalt-60 sources, secondary collimation helmets of 4-18 mm, Leksell frame-based targeting with sub-millimetric accuracy; LINAC-based systems and CyberKnife (robotic, frameless, image-tracked) are the alternatives.
- Dose landmarks: vestibular schwannoma 12-13 Gy to margin; arteriovenous malformation margin around 18-25 Gy aiming at nidus obliteration; metastases 18-24 Gy; trigeminal neuralgia 75-80 Gy maximum to the retro-Gasserian root; the optic apparatus tolerates only about 8-10 Gy in a single fraction — the planning constraint that forbids some sellar targets.
- The latency lesson: arteriovenous malformations obliterate over two to three years, and haemorrhage risk — roughly 2-4 per cent per year in the latency window — persists until angiographic cure; radiosurgery is not instant protection.
- Vestibular schwannoma trade: growth control in the large majority (over 90 per cent in most series), hearing preservation roughly half to two-thirds where serviceable at treatment, facial numbness a few per cent.
- Adverse radiation effect: delayed oedema or radionecrosis in the surrounding brain weeks to months later, managed with steroids and, in refractory cases, bevacizumab per current practice.
- Indian access reality: Gamma Knife units are few and metro-concentrated; LINAC-based stereotactic radiosurgery is the more widely available Indian workhorse — a genuine determinant of what a DM candidate will practise.
Where candidates slip
The classic error is crediting radiosurgery with instant protection — "the arteriovenous malformation is treated, so it cannot bleed" — when the latency period carries a continued, meaningful haemorrhage risk until obliteration is proven on angiography. The second is the misconception that single-fraction tolerance is universal: the optic chiasm and pathways tolerate only about 8-10 Gy in one fraction, which is why a pituitary adenoma abutting the chiasm may need fractionated delivery or surgery instead. The third is forgetting what radiosurgery cannot do — decompress. A skull base meningioma compressing the brainstem with mass effect needs debulking first; irradiating a compressive lesion and waiting months is a counsel of delay.
Frequently asked questions
What hardware defines Gamma Knife radiosurgery?
Two hundred and one cobalt-60 sources converging through 4, 8, 14 and 18 mm collimator helmets onto a Leksell frame-defined target in a single session.
Why does an arteriovenous malformation remain dangerous after radiosurgery?
Obliteration takes two to three years, and the haemorrhage risk of roughly 2-4 per cent per year persists until angiographic cure is confirmed.
What marginal dose is standard for a small vestibular schwannoma?
Approximately 12-13 Gy to the tumour margin, balancing growth control over 90 per cent with serviceable hearing preservation in roughly half to two-thirds.
What is the single-fraction tolerance of the optic apparatus?
About 8-10 Gy maximum, the planning constraint that diverts chiasm-apposing tumours to fractionated therapy or microsurgery.
How does radiosurgery differ from fractionated radiotherapy biologically?
It delivers a very high single dose with steep falloff, exploiting normal tissue repair differences to injure the target sharply while sparing surrounding brain, rather than spreading dose over weeks.